Once every two weeks, TheBodyPRO.com sends its subscribers an email newsletter highlighting some of the most noteworthy HIV/AIDS-related news and research headlines recently added to TheBodyPRO.com, as well as a selection of personal perspectives and patient-friendly materials from TheBody.com, TheBodyPRO.com's sister site geared toward the general HIV/AIDS community.
Below is an online archive of each of our email newsletters. If you'd like to sign up, just complete your free registration at TheBodyPRO.com. If you're an existing member and you'd like to modify your settings or unsubsribe from our email newsletters, please log in and modify your account information.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|